AU2001280105A1 - Methof of regulating apoptosis and apoptosis-regulatory polypeptide - Google Patents
Methof of regulating apoptosis and apoptosis-regulatory polypeptideInfo
- Publication number
- AU2001280105A1 AU2001280105A1 AU2001280105A AU8010501A AU2001280105A1 AU 2001280105 A1 AU2001280105 A1 AU 2001280105A1 AU 2001280105 A AU2001280105 A AU 2001280105A AU 8010501 A AU8010501 A AU 8010501A AU 2001280105 A1 AU2001280105 A1 AU 2001280105A1
- Authority
- AU
- Australia
- Prior art keywords
- apoptosis
- methof
- regulating
- regulatory polypeptide
- regulatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000251529 | 2000-08-22 | ||
JP2000-251529 | 2000-08-22 | ||
PCT/JP2001/007179 WO2002015925A1 (en) | 2000-08-22 | 2001-08-22 | Methof of regulating apoptosis and apoptosis-regulatory polypeptide |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001280105A1 true AU2001280105A1 (en) | 2002-03-04 |
Family
ID=18740921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001280105A Abandoned AU2001280105A1 (en) | 2000-08-22 | 2001-08-22 | Methof of regulating apoptosis and apoptosis-regulatory polypeptide |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2002015925A1 (en) |
AU (1) | AU2001280105A1 (en) |
WO (1) | WO2002015925A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA81634C2 (en) * | 2002-07-18 | 2008-01-25 | Хеликс Биофарма Корп. | Pharmaceutical compoosition containing urease for inhibiting cancer cell growth |
US7959915B2 (en) | 2003-03-12 | 2011-06-14 | Tufts University | Inhibitors of extracellular Hsp90 |
AU2005221470B2 (en) * | 2003-03-12 | 2010-05-20 | Tufts University | Inhibitors of extracellular hsp90 |
US20050020556A1 (en) * | 2003-05-30 | 2005-01-27 | Kosan Biosciences, Inc. | Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes |
US7691838B2 (en) * | 2003-05-30 | 2010-04-06 | Kosan Biosciences Incorporated | Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics |
WO2008032876A1 (en) * | 2006-09-15 | 2008-03-20 | Tokai University | Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
EA019156B1 (en) | 2008-02-01 | 2014-01-30 | Такеда Фармасьютикал Компани Лимитед | Oxim derivatives as hsp90 inhibitors |
-
2001
- 2001-08-22 JP JP2002520846A patent/JPWO2002015925A1/en not_active Withdrawn
- 2001-08-22 WO PCT/JP2001/007179 patent/WO2002015925A1/en active Application Filing
- 2001-08-22 AU AU2001280105A patent/AU2001280105A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002015925A1 (en) | 2002-02-28 |
JPWO2002015925A1 (en) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5468499A (en) | 3-methylidenyl-2-indolinone modulators of protein kinase | |
AU4505997A (en) | Sulfonamides and derivatives thereof that modulate the activity of endothelin | |
AU2001234473A1 (en) | Stabilized silica and methods of making and using the same | |
AU2002217926A1 (en) | Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same | |
AU2001293189A1 (en) | Compositions and methods for regulating apoptosis | |
AU2003286746A1 (en) | Modulators of angiogenesis and tumorigenesis | |
AU2002329231A1 (en) | Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof | |
AU6143998A (en) | Regulators of apoptosis | |
AU2002320470A1 (en) | Modulators of ceramidase and methods of use based thereon | |
AU2001280105A1 (en) | Methof of regulating apoptosis and apoptosis-regulatory polypeptide | |
AU2002366310A1 (en) | Method of inducing apoptosis and compositions therefor | |
AU3241895A (en) | Apoptosis related protein bcl-y, and methods of use thereof | |
AU2587499A (en) | Suppression of alpha-amylase and protease expression using serine/threonine protein kinase | |
AU1126000A (en) | Proliferation and apoptosis related proteins | |
AU4445701A (en) | Multiple human and mouse otoferlin isoforms | |
AU2001275063A1 (en) | Regulators of apoptosis | |
AU2388800A (en) | Stable subtilin and methods of manufacture | |
AU2001284380A1 (en) | Therapeutic and cosmetic uses of heparanases | |
AU3289599A (en) | Mekk1 proteins and fragments thereof for use in regulating apoptosis | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU2003277537A1 (en) | REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 | |
AU2211100A (en) | Therapeutic applications of flint polypeptides | |
AU2003297554A1 (en) | Modulation of death-associated protein kinase 1 expression | |
AU2001277750A1 (en) | Use of polypeptide | |
AU2001293780A1 (en) | Regulation of human protein phosphatase iic-like enzyme |